news 2022

VUB research suggests pain education and lifestyle are important components of a multimodal approach to treat persistent pain Friday, February 4, 2022 — 4 February is #WorldCancerDay After cancer treatment, many patients continue to suffer from pain. About four out of ten cancer survivors have chronic pain complaints.

World Cancer Day, 4 February: Award-winning research on incurable blood cancer Researchers at the Vrije Universiteit Brussel, led by Eline Menu, have investigated how changes in metabolism contribute to cancer resistance and relapse.

AI system can predict risk of heart attack based on retinal scan An international team of researchers have developed an AI system that can identify patients who are likely to have a heart attack over the next year. The system reads retinal scans that are already commonly used in eye clinics. Doctors have recognised that changes to the tiny blood vessels in the retina are indicators of broader vascular disease, including problems with the heart.

Two research groups from the Vrije Universiteit Brussel have established a collaboration in which they predict the response to the standard treatment for rectal cancer based on medical images (e.g.

In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defence against tumours.

In brief: Parkinson's disease is the second most common neurodegenerative disease, but we still do not understand why this disease occurs. Scientists from the UCLouvain de Duve Institute have discovered a new type of molecular damage that is (glycolysis). They also discovered a mechanism that allows cells to prevent this type of damage.

Researcher returns from US with state-of-the-art knowledge Friday, January 21, 2022 — VUB scientist Gamze Ates has been awarded €100,000 for research into Alzheimer's disease.

VUB research shows that living close to wetlands increases risk of diseases such as malaria or pulmonary infections such as possible Tuberculosis Wednesday, January 12, 2022 — For her PhD at the Vrije Universiteit Brussel and the University of Sheffield, Dr. Marit Van Cant studied medieval to early modern skeletal populations from six archaeological sites in Flanders.